Elasmogen, which are part of the Deepbridge Life Sciences EIS portfolio, has been announced as a finalist in the Innovative Collaboration award at Scotland's Life Sciences Awards. 

Scotland's Life Sciences Awards invite businesses in the growing life sciences sector across Scotland to apply for up to seven categories. The Award of a Lifetime Achievement will also be awarded as a special award from the panel of judges on the night. This will be given to an individual considered to have contributed significantly to Scotland's Life Sciences sector. 

Winners of each categories will be announced in Scotland's Life Sciences Awards Dinner on the 19th March 2020.

To find out more, click here. 

About Elasmogen

Elasmogen Ltd is a biologics company that was spun out of the University of Aberdeen and has developed a proprietary ‘soloMER’ platform. Specifically, the Company’s technology comprises a platform exploiting the power of biologics as drugs in small, simple and stable formats (‘soloMERs’).  Specifically, they are small (i.e. 9% of the size of a human antibody) and highly stable proteins, making them ideal for both site-specific delivery and the penetration of solid cancerous tumours.